Loading clinical trials...
Loading clinical trials...
Use of Cannabidiol (CBD) Oil in the Treatment of PTSD: A Placebo-Controlled Randomized Clinical Trial
Conditions
Interventions
CBD Isolate
CBD Broad Spectrum
+1 more
Locations
1
United States
Laboratory for the Study of Anxiety Disorders, University of Texas at Austin
Austin, Texas, United States
Start Date
January 15, 2020
Primary Completion Date
May 1, 2024
Completion Date
May 1, 2025
Last Updated
November 22, 2023
NCT07288151
NCT07485231
NCT06947538
NCT07462312
NCT07351305
NCT05467683
Lead Sponsor
University of Texas at Austin
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions